• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Breakthrough approach for treating mastitis in dairy cows

May 8, 2023
dvm360 Staff

Two companies partner to combat issue of antibiotic resistance and improve animal health

Amicogen, a biotech company focusing on industrial enzyme production and drug development, has teamed up with Lysando, an innovative biotech company with a background in the development of antimicrobial Artilysin, to address the increasing issue of mastitis in dairy cows caused by multi-resistant bacteria.

A company release1 cites that the overuse of antibiotics in animal husbandry has been causing a rapid increase in multidrug-resistant pathogens. About 70% of all antibiotics produced around the world are used in agriculture, often as preventative measures, which has advanced the spread of resistances.

Mastitis is a bacterial infection of the udder caused by various, often multi-resistant strains of bacteria, and is rapidly spreading, particularly in Asia. This causes animal suffering and a substantial wastage of milk production, resulting in a $20-30 billion annual revenue loss for the dairy industry.1

Amicogen and Lysando are maximizing their combined expertise to create an innovative treatment that is effective and sustainable, reducing the economic impact of mastitis on farmers while enhancing animal welfare.

Advertisement

“We are excited to partner with Lysando to develop a novel and innovative solution against mastitis in dairy cows,” said Dr Park, CEO of Amicogen, in the release.1 “This collaboration highlights the growing importance of joining forces in biotech and the potential for innovation to address critical challenges – also in agriculture.”

“Our Artilysin technology has shown great promise in addressing bacterial infections and we believe that this partnership will make a real difference in the fight against mastitis,” added Kerstin Emmrich, PhD, director R&D, Lysando AG.

Reference

Amicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows. News release. Amicogen; Lysando. May 8, 2023. Accessed May 8, 2023. https://www.businesswire.com/news/home/20230508005095/en

Related Content:

ProductsInfectious Diseases
Details of new pet performance supplement line revealed
Details of new pet performance supplement line revealed
New Automatic 2-in-1 Pet Feeder and Water Dispenser launched
New Automatic 2-in-1 Pet Feeder and Water Dispenser launched
dvm360® product report: One Health microsite, plus mushroom equine supplement and more
dvm360® product report: One Health microsite, plus mushroom equine supplement and more

Advertisement

Latest News

Can our Pride panel answer these LGBTQ+ trivia questions?

Creating inclusive spaces for the LGBTQ+ community in vet med

Happy Pride Month, Hill's launches Prescription Diet ONC Care, and more

CityVet Celina opens in Prosper, Texas

View More Latest News
Advertisement